Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
9.38
+0.84 (9.84%)
May 5, 2026, 11:03 AM EDT - Market open
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$752,000
Profits / Employee
-$9,556
Market Cap
483.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 900 | 0 | - |
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 960 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 334 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 147 |
EBS News
- 4 days ago - Emergent BioSolutions Earnings Call Transcript: Q1 2026 - Transcripts
- 4 days ago - Emergent BioSolutions Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 5 days ago - Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox - GlobeNewsWire
- 6 days ago - Emergent BioSolutions Transcript: AGM 2026 - Transcripts
- 6 days ago - Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142 - GlobeNewsWire
- 6 days ago - Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives - GlobeNewsWire
- 7 days ago - Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States - GlobeNewsWire
- 18 days ago - Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026 - GlobeNewsWire